Too Tired for More: How Best to Treat Multifactorial Fatigue
Fatigue: a very common physical complaint that often accompanies depressive disorders.
Source: psychiatrictimes.com
Lupus Sci News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Lupus Sci. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Lupus Sci Today - Breaking & Trending Today
Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2 Trial Evaluating Daxdilimab for the Treatment of Discoid Lupus Erythematosus
Horizon Therapeutics plc (Nasdaq: HZNP) today announced the first patient has enrolled in a Phase 2, randomized, placebo-controlled trial to evaluate its development-stage medicine daxdilimab, a potentially
Source: finanznachrichten.de
Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2 Trial Evaluating Daxdilimab for the Treatment of Discoid Lupus Erythematosus | Antibodies
Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2 Trial Evaluating Daxdilimab for the Treatment of Discoid Lupus Erythematosus
Source: pipelinereview.com
Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Saphnelo approved in EU for SLE
Investegate announcements from AstraZeneca PLC, Saphnelo approved in EU for SLE
Source: investegate.co.uk
Saphnelo approved in the EU for the treatment of moderate to severe systemic lupus erythematosus
AstraZeneca’s Saphnelo (anifrolumab) has been approved in the European Union as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (SLE), despite receiving standard therapy. Saphnelo is the first biologic for SLE approved in ...
Source: pharmiweb.com